Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults

Clinical trial NCT06984094 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06984094
Sponsor: Clover Biopharmaceuticals AUS Pty
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

RSV Infection Human Metapneumovirus Infection Parainfluenza Infection

Start date: 2025-06-18
Primary completion: 2028-03-01
Enrollment: 612

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.